Ligand validation:5NLO

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5NLO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5NLO_NAG_A_302	78%	33%	0.106	0.947	1.38	1.27	1	2	0	0	100%	0.9333
5NLO_NAG_A_304	5%	22%	0.246	0.661	0.98	2.22	1	6	2	0	93%	0.4667
5NLO_NAG_A_303	3%	49%	0.345	0.697	1.02	0.97	1	1	2	0	100%	0.7
5ACH_NAG_A_401	89%	58%	0.088	0.967	0.76	0.86	-	-	0	0	100%	0.9333
5NKW_NAG_A_302	79%	29%	0.098	0.943	1.28	1.57	2	3	0	0	100%	0.9333
7PXV_NAG_A_302	77%	56%	0.103	0.942	0.47	1.2	-	1	0	0	100%	0.9333
5NLQ_NAG_A_302	77%	51%	0.112	0.951	0.77	1.13	-	1	0	0	100%	0.9333
7PXM_NAG_A_302	70%	50%	0.096	0.911	0.75	1.16	-	1	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
4AKM_NAG_A_1379	100%	67%	0.029	0.994	0.54	0.73	-	-	0	0	100%	0.9333
3CQL_NAG_B_244	100%	68%	0.029	0.987	0.42	0.8	-	-	0	0	100%	1
3RIK_NAG_D_509	100%	8%	0.035	0.991	2.03	2.54	4	7	2	0	100%	0.9333
5VEM_NAG_B_509	100%	74%	0.003	0.957	0.46	0.56	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.